TeleVox Awarded AI Chatbot Agreement with Premier, Inc.
2024年11月6日 - 11:00PM
TeleVox, the industry-leading provider of omnichannel patient
relationship management platforms, has been awarded a national
group purchasing agreement for AI chatbots with Premier, Inc. the
agreement allows Premier members, at their discretion, to take
advantage of special pricing and terms pre-negotiated by Premier
for TeleVox’s SMART Web, SMART Voice, and SMART SMS powered by
Iris, the conversational AI virtual agent for healthcare.
“This agreement extends the reach of Iris, our industry leading
conversational AI platform, to thousands more hospitals and
healthcare facilities around the country,” said Steve Ganjoo, Head
of Channel Partnerships at TeleVox. “We welcome the opportunity to
showcase to Premier members how Iris can ease the burden on
healthcare staff and foster better relationships between providers
and patients.”
Iris was introduced in 2023 as a new standard for conversational
virtual assistants. With its advanced AI capabilities, Iris enables
self-service opportunities, answers a wide range of inquiries
without requiring custom content development and, if necessary,
connects the patient to appropriate staff via Chat. Iris stands out
with its omni-channel experience across SMART Web, SMART Voice, and
SMART SMS to meet patients where they are. Iris can be easily
integrated with existing EHRs or deployed as a standalone solution,
ensuring a seamless patient relationship management experience.
Premier is a leading healthcare improvement company, uniting an
alliance of approximately 4,350 U.S. hospitals and 325,000 other
providers and organizations to transform healthcare. With
integrated data and analytics, collaboratives, supply chain
solutions, consulting and other services, Premier enables better
care and outcomes at a lower cost.
About TeleVoxTeleVox is a leading provider of
omnichannel digital patient relationship management technology. Our
solutions are trusted by more than 7,000 healthcare organizations,
including hospitals, health systems, and community health centers,
to engage, educate, and empower patients throughout their care
journey. Our patient relationship management platform integrates
seamlessly with the electronic health record (EHR) to support
automated, personalized, two-way interactions with patients.
Additionally, our pharmaceutical team partners with life science
companies to develop strategic disease state awareness, education,
and vaccination reminders, reaching more patients through
customized communication. All of these exchanges are made possible
via text, virtual assistant, interactive voice response (IVR),
email, and postcards. For 30 years, TeleVox has helped preserve
care continuity, reduce the operational burden on staff, and drive
revenue, making the healthcare communication process easier for
everyone. TeleVox is part of West Technology Group, LLC, controlled
by affiliates of certain funds managed by Apollo Global Management,
Inc. (NYSE: APO).
For more information, please visit www.televox.com.
Contact:Hilary CooperHead of
Marketinghilary.cooper@mosaicx.com 404.441.0286
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/2dbd054d-782f-44ef-99aa-b1ae1c5fb97f
Apollo Global Management (NYSE:APO)
過去 株価チャート
から 11 2024 まで 12 2024
Apollo Global Management (NYSE:APO)
過去 株価チャート
から 12 2023 まで 12 2024